The analysis presents three stock picks for long-term investment: Colgate-Palmolive (CP), Mastercard (MA), and CVS Health (CVS). For Colgate-Palmolive, a discounted cash flow valuation model suggests the stock is undervalued, with a present value of free cash flow estimated at over $127 billion. For Mastercard, the present value of free cash flow is projected to be over $491 billion. And for CVS Health, analysis forecasts over $4 billion in free cash flow, with an estimated value of $181 billion. These projections inform the 'hold almost forever' recommendation for each stock, indicating strong confidence in their long-term financial viability.